57464 Federal Register / Vol. 88, No. 162 / Wednesday, August 23, 2023 / Notices 

2. The dissemination of information 

to the public on clinical study 

enrollment demographic data. 

3. The establishment of goals for 

clinical study enrollment, including the 

relevance of disease prevalence and 

incidence. 

4. The approaches to include 

underrepresented populations and 

encourage participation that reflects the 

population expected to use the drug or 

device, if approved, including: 

A. The establishment of inclusion and 

exclusion criteria for certain subgroups, 

such as pregnant and lactating women 

and individuals with disabilities, 

including intellectual or developmental 

disabilities or mental illness. 

B. The considerations regarding 

informed consent with respect to 

individuals with intellectual or 

developmental disabilities or mental 

illness, including ethical and scientific 

considerations. 

C. The appropriate use of 

decentralized trials or digital health 

tools, clinical endpoints, biomarker 

selection, and studying analysis. 

III. Participating in the Public 

Workshop 

Registration: To register for the public 

workshop, please visit the following 

website: https://duke.zoom.us/meeting/ 

register/tJcrceuhqjgvE9zGjDNOURONo

JZvxrpK4Rvi#/registration. Please 

provide complete contact information 

for each attendee, including name, title, 

affiliation, address, email, and 

telephone. 

Registration is free, and persons 

interested in attending this public 

workshop must register to receive a link 

to the meeting. Registrants will receive 

a confirmation email after they register. 

If you need special accommodations 

due to a disability, please contact 

Sabrena Mervin-Blake, 919–724–0715, 

sabrena.mervin-blake@duke.edu no 

later than November 15, 2023. Please 

note, closed captioning and American 

Sign Language will be available 

automatically. 

Dated: August 18, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–18149 Filed 8–22–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Eunice Kennedy 

Shriver National Institute of Child Health 

and Human Development Special Emphasis 

Panel; PS/Member Conflict. 

Date: October 5, 2023. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Eunice 

Kennedy Shriver National Institute of Child 

Health and Human Development, 6710B 

Rockledge Drive, Room 2137B, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Vera A. Cherkasova, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health, and Human 

Development National Institutes of Health, 

6710B Rockledge Drive, Room 2137B, 

Bethesda, MD 20892, (240) 478–4580, 

vera.cherkasova@nih.gov. 

Name of Committee: Eunice Kennedy 

Shriver National Institute of Child Health 

and Human Development Special Emphasis 

Panel; Ruth L. Kirschstein National Research 

Service Award (NRSA) Institutional Research 

Training Grant Review. 

Date: November 2–3, 2023. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: North Bethesda Marriott Hotel and 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Christiane M. Robbins, 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2125D, 

Bethesda, MD 20892, (301) 451–4989, 

crobbins@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.865, Research for Mothers 

and Children, National Institutes of Health, 

HHS) 

Dated: August 18, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–18145 Filed 8–22–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; External Quality Assurance 

Program Oversight Laboratory (EQAPOL), 

RFP: 75N93022R00034. 

Date: September 15, 2023. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G21B, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Robert C. Unfer, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G21B, Rockville, MD 

20852, 240–669–5035. unferrc@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 18, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–18147 Filed 8–22–23; 8:45 am] 

BILLING CODE 4140–01–P 


lotter on DSK11XQN23PROD with NOTICES1